SRRA - シエラ・オンコロジ― (Sierra Oncology Inc.)

SRRAのニュース

   Karyopharm Therapeutics (NASDAQ:KPTI) versus Sierra Oncology (NASDAQ:SRRA) Head-To-Head Contrast  2020/10/24 23:00:43 Daily Political
Karyopharm Therapeutics (NASDAQ:KPTI) and Sierra Oncology (NASDAQ:SRRA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, dividends, analyst recommendations and profitability. Insider & Institutional Ownership 95.9% of Karyopharm Therapeutics shares are owned by institutional investors. Comparatively, […]
   Karyopharm Therapeutics (NASDAQ:KPTI) and Sierra Oncology (NASDAQ:SRRA) Critical Contrast  2020/10/22 20:14:46 US Banking News
Karyopharm Therapeutics (NASDAQ:KPTI) and Sierra Oncology (NASDAQ:SRRA) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, valuation and institutional ownership. Insider & Institutional Ownership 95.9% of Karyopharm Therapeutics shares are owned by institutional investors. Comparatively, […]
   The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology  2020/02/11 12:23:06 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 10) AbbVie Inc (NYSE: ABBV ) Allergan plc (NYSE: AGN ) )(reacted to better-than-expected results and comments that its deal to be acquired by AbbVie is on track to close by the first quarter) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Aptose Biosciences Inc (NASDAQ: APTO ) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Ascendis Pharma A/S (NASDAQ: ASND ) AtriCure Inc. (NASDAQ: ATRC ) ChemoCentryx Inc (NASDAQ: CCXI ) Co-Diagnostics Inc (NASDAQ: CODX )(announced sales of its new coronavirus test ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) DexCom, Inc. (NASDAQ: DXCM ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Insulet Corporation (NASDAQ: PODD ) Kodiak Sciences Inc (NASDAQ: KOD )(reacted to positive data readout from early-stage study of experimental drug to treat eye disorders) Masimo Corporation (NASDAQ: MASI ) Novartis AG (NYSE: NVS ) Pacira Biosciences Inc (NASDAQ: PCRX ) Principia Biopharma Inc (NASDAQ: PRNB ) PTC Therapeutics, Inc (NASDAQ: PTCT ) Revance Therapeutics Inc (NASDAQ: RVNC ) ResMed Inc.
   Sierra Oncology Completes Conversion of Preferred to Common Stock and Issues Stock to Gilead  2020/02/06 12:00:00 PR Newswire
/PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage drug development company focused on the development and commercialization of momelotinib, a JAK1,…
   Sierra Oncology : Shares Drop 12% Before Reverse Stock Split | MarketScreener  2020/01/22 18:08:02 MarketScreener
By Chris Wack Sierra Oncology shares dropped 12% to 34 cents after the company said its board of directors approved a reverse stock split of its shares at a ratio of 1-for-40, effective… | January 22, 2020
   Karyopharm Therapeutics (NASDAQ:KPTI) versus Sierra Oncology (NASDAQ:SRRA) Head-To-Head Contrast  2020/10/24 23:00:43 Daily Political
Karyopharm Therapeutics (NASDAQ:KPTI) and Sierra Oncology (NASDAQ:SRRA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, dividends, analyst recommendations and profitability. Insider & Institutional Ownership 95.9% of Karyopharm Therapeutics shares are owned by institutional investors. Comparatively, […]
   Karyopharm Therapeutics (NASDAQ:KPTI) and Sierra Oncology (NASDAQ:SRRA) Critical Contrast  2020/10/22 20:14:46 US Banking News
Karyopharm Therapeutics (NASDAQ:KPTI) and Sierra Oncology (NASDAQ:SRRA) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, valuation and institutional ownership. Insider & Institutional Ownership 95.9% of Karyopharm Therapeutics shares are owned by institutional investors. Comparatively, […]
   The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology  2020/02/11 12:23:06 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 10) AbbVie Inc (NYSE: ABBV ) Allergan plc (NYSE: AGN ) )(reacted to better-than-expected results and comments that its deal to be acquired by AbbVie is on track to close by the first quarter) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Aptose Biosciences Inc (NASDAQ: APTO ) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Ascendis Pharma A/S (NASDAQ: ASND ) AtriCure Inc. (NASDAQ: ATRC ) ChemoCentryx Inc (NASDAQ: CCXI ) Co-Diagnostics Inc (NASDAQ: CODX )(announced sales of its new coronavirus test ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) DexCom, Inc. (NASDAQ: DXCM ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Insulet Corporation (NASDAQ: PODD ) Kodiak Sciences Inc (NASDAQ: KOD )(reacted to positive data readout from early-stage study of experimental drug to treat eye disorders) Masimo Corporation (NASDAQ: MASI ) Novartis AG (NYSE: NVS ) Pacira Biosciences Inc (NASDAQ: PCRX ) Principia Biopharma Inc (NASDAQ: PRNB ) PTC Therapeutics, Inc (NASDAQ: PTCT ) Revance Therapeutics Inc (NASDAQ: RVNC ) ResMed Inc.
   Sierra Oncology Completes Conversion of Preferred to Common Stock and Issues Stock to Gilead  2020/02/06 12:00:00 PR Newswire
/PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage drug development company focused on the development and commercialization of momelotinib, a JAK1,…
   Sierra Oncology : Shares Drop 12% Before Reverse Stock Split | MarketScreener  2020/01/22 18:08:02 MarketScreener
By Chris Wack Sierra Oncology shares dropped 12% to 34 cents after the company said its board of directors approved a reverse stock split of its shares at a ratio of 1-for-40, effective… | January 22, 2020
   Karyopharm Therapeutics (NASDAQ:KPTI) versus Sierra Oncology (NASDAQ:SRRA) Head-To-Head Contrast  2020/10/24 23:00:43 Daily Political
Karyopharm Therapeutics (NASDAQ:KPTI) and Sierra Oncology (NASDAQ:SRRA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, dividends, analyst recommendations and profitability. Insider & Institutional Ownership 95.9% of Karyopharm Therapeutics shares are owned by institutional investors. Comparatively, […]
   Karyopharm Therapeutics (NASDAQ:KPTI) and Sierra Oncology (NASDAQ:SRRA) Critical Contrast  2020/10/22 20:14:46 US Banking News
Karyopharm Therapeutics (NASDAQ:KPTI) and Sierra Oncology (NASDAQ:SRRA) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, valuation and institutional ownership. Insider & Institutional Ownership 95.9% of Karyopharm Therapeutics shares are owned by institutional investors. Comparatively, […]
   The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology  2020/02/11 12:23:06 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 10) AbbVie Inc (NYSE: ABBV ) Allergan plc (NYSE: AGN ) )(reacted to better-than-expected results and comments that its deal to be acquired by AbbVie is on track to close by the first quarter) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Aptose Biosciences Inc (NASDAQ: APTO ) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Ascendis Pharma A/S (NASDAQ: ASND ) AtriCure Inc. (NASDAQ: ATRC ) ChemoCentryx Inc (NASDAQ: CCXI ) Co-Diagnostics Inc (NASDAQ: CODX )(announced sales of its new coronavirus test ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) DexCom, Inc. (NASDAQ: DXCM ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Insulet Corporation (NASDAQ: PODD ) Kodiak Sciences Inc (NASDAQ: KOD )(reacted to positive data readout from early-stage study of experimental drug to treat eye disorders) Masimo Corporation (NASDAQ: MASI ) Novartis AG (NYSE: NVS ) Pacira Biosciences Inc (NASDAQ: PCRX ) Principia Biopharma Inc (NASDAQ: PRNB ) PTC Therapeutics, Inc (NASDAQ: PTCT ) Revance Therapeutics Inc (NASDAQ: RVNC ) ResMed Inc.
   Sierra Oncology Completes Conversion of Preferred to Common Stock and Issues Stock to Gilead  2020/02/06 12:00:00 PR Newswire
/PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage drug development company focused on the development and commercialization of momelotinib, a JAK1,…
   Sierra Oncology : Shares Drop 12% Before Reverse Stock Split | MarketScreener  2020/01/22 18:08:02 MarketScreener
By Chris Wack Sierra Oncology shares dropped 12% to 34 cents after the company said its board of directors approved a reverse stock split of its shares at a ratio of 1-for-40, effective… | January 22, 2020

calendar